eQcell is a Canadian regenerative medicine company developing allogeneic stem-cell-based therapies for animal health and future translational applications. Public materials describe the company as a clinical-stage regenerative medicine business using equine cord blood stem cells and canine adipose-derived mesenchymal stromal cells to create off-the-shelf therapeutics. Its strategy is built around one-health principles that connect veterinary and human regenerative medicine.